1. Home
  2. STRO vs FURY Comparison

STRO vs FURY Comparison

Compare STRO & FURY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • FURY
  • Stock Information
  • Founded
  • STRO 2003
  • FURY 2008
  • Country
  • STRO United States
  • FURY Canada
  • Employees
  • STRO N/A
  • FURY N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • FURY Precious Metals
  • Sector
  • STRO Health Care
  • FURY Basic Materials
  • Exchange
  • STRO Nasdaq
  • FURY Nasdaq
  • Market Cap
  • STRO 77.7M
  • FURY 91.4M
  • IPO Year
  • STRO 2018
  • FURY N/A
  • Fundamental
  • Price
  • STRO $0.76
  • FURY N/A
  • Analyst Decision
  • STRO Hold
  • FURY Strong Buy
  • Analyst Count
  • STRO 7
  • FURY 1
  • Target Price
  • STRO $3.97
  • FURY $1.20
  • AVG Volume (30 Days)
  • STRO 1.4M
  • FURY 288.0K
  • Earning Date
  • STRO 08-12-2025
  • FURY 08-07-2025
  • Dividend Yield
  • STRO N/A
  • FURY N/A
  • EPS Growth
  • STRO N/A
  • FURY N/A
  • EPS
  • STRO N/A
  • FURY N/A
  • Revenue
  • STRO $66,434,000.00
  • FURY N/A
  • Revenue This Year
  • STRO N/A
  • FURY N/A
  • Revenue Next Year
  • STRO N/A
  • FURY N/A
  • P/E Ratio
  • STRO N/A
  • FURY N/A
  • Revenue Growth
  • STRO N/A
  • FURY N/A
  • 52 Week Low
  • STRO $0.52
  • FURY $0.35
  • 52 Week High
  • STRO $5.17
  • FURY $0.56
  • Technical
  • Relative Strength Index (RSI)
  • STRO 44.92
  • FURY 57.85
  • Support Level
  • STRO $0.67
  • FURY $0.50
  • Resistance Level
  • STRO $0.79
  • FURY $0.52
  • Average True Range (ATR)
  • STRO 0.07
  • FURY 0.03
  • MACD
  • STRO -0.01
  • FURY -0.00
  • Stochastic Oscillator
  • STRO 34.52
  • FURY 48.89

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.

Share on Social Networks: